TODD ROSENGART to Coronary Artery Disease
This is a "connection" page, showing publications TODD ROSENGART has written about Coronary Artery Disease.
Connection Strength
1.943
-
Total arterial revascularization: when will its time come? J Thorac Cardiovasc Surg. 2014 Oct; 148(4):1244-5.
Score: 0.260
-
Cardiac cellular reprogramming. Tex Heart Inst J. 2013; 40(5):581-2.
Score: 0.231
-
Long-term follow-up assessment of a phase 1 trial of angiogenic gene therapy using direct intramyocardial administration of an adenoviral vector expressing the VEGF121 cDNA for the treatment of diffuse coronary artery disease. Hum Gene Ther. 2013 Feb; 24(2):203-8.
Score: 0.231
-
Double-blinded, placebo-controlled, randomized gene therapy using surgery for vector delivery. Hum Gene Ther. 2012 May; 23(5):438-41.
Score: 0.221
-
Low socioeconomic status adversely influences outcomes after coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2025 11; 170(5):1480-1490.e5.
Score: 0.133
-
Emerging role of positron emission tomography (PET) imaging in cardiac surgery. J Card Surg. 2022 Dec; 37(12):4158-4164.
Score: 0.114
-
Racial/ethnic differences persist in treatment choice and outcomes in isolated intervention for coronary artery disease. J Thorac Cardiovasc Surg. 2023 10; 166(4):1087-1096.e5.
Score: 0.109
-
Single-Dose del Nido Cardioplegia Compared With Standard Cardioplegia During Coronary Artery Bypass Grafting at a Veterans Affairs Hospital. Tex Heart Inst J. 2021 01 01; 48(1).
Score: 0.101
-
Development of a Risk Score to Predict 90-Day Readmission After Coronary Artery Bypass Graft. Ann Thorac Surg. 2021 02; 111(2):488-494.
Score: 0.097
-
Incidence, Predictors, and Impact of Postoperative Atrial Fibrillation after Coronary Artery Bypass Grafting in Military Veterans. Tex Heart Inst J. 2016 Oct; 43(5):397-403.
Score: 0.075
-
Trends in Robotic-Assisted Coronary Artery Bypass Grafts: A Study of The Society of Thoracic Surgeons Adult Cardiac Surgery Database, 2006 to 2012. Ann Thorac Surg. 2016 Jul; 102(1):140-6.
Score: 0.072
-
Changes over time in risk profiles of patients who undergo coronary artery bypass graft surgery: the Veterans Affairs Surgical Quality Improvement Program (VASQIP). JAMA Surg. 2015 Apr; 150(4):308-15.
Score: 0.068
-
Completeness of coronary revascularization and survival: Impact of?age and off-pump surgery. J Thorac Cardiovasc Surg. 2014 Oct; 148(4):1307-1315.e1.
Score: 0.062
-
Gene therapy to stimulate angiogenesis to treat diffuse coronary artery disease. Hum Gene Ther. 2013 Nov; 24(11):948-63.
Score: 0.061
-
Safety of Early Discharge After Coronary Artery Bypass Grafting: A Nationwide Readmissions Analysis. Ann Thorac Surg. 2024 09; 118(3):701-710.
Score: 0.032
-
Safety of local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of morbid conditions. Hum Gene Ther. 2002 Jan 01; 13(1):15-63.
Score: 0.027
-
Analysis of risk factors for local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of comorbid conditions. Hum Gene Ther. 2002 Jan 01; 13(1):65-100.
Score: 0.027
-
Risk analysis of primary versus reoperative coronary artery bypass grafting. Ann Thorac Surg. 1993 Nov; 56(5 Suppl):S74-7.
Score: 0.015
-
Systemic interleukin-6 responses following administration of adenovirus gene transfer vectors to humans by different routes. Mol Ther. 2002 Aug; 6(2):287-97.
Score: 0.007